Life Sciences
Marker Learning, which provides virtual assessments for learning disabilities, raised $15 million, and reproductive care company Twentyeight Health scored $8.3 million.
It will be used to invest in specialised healthcare logistics and financing, among other plans.
Austin Speier, chief strategy officer at Click Therapeutics, discusses the company's expanded partnership with Boehringer Ingelheim.
Science 37 said the purchase will improve its clinical trial workflow and data interoperability capabilities.
OncoPower users will have access to Cost Plus Drugs' prescriptions through the partners' Medication Savings Suite.
Cough-monitoring company C-mo Medical Solutions and sexual healthcare provider TBD Health also announced funding rounds.
The funds will help the company grow its platform and scale partnerships with life science companies and healthcare systems.
They seek to identify digital predictive biomarkers of narcolepsy and excessive daytime sleeping.
The grocery chain's healthcare division also announced its first trial, a collaboration with Persephone Biosciences.
RxPass, which will be available to Prime members, will offer generic drugs for common conditions like high blood pressure and anxiety.